GLOBAL BURDEN OF HIP FRACTURES
EUROPE
Aarhus University
Prof. Henrik T. Sørensen
Department of Clinical Epidemiology,
Aarhus University, Denmark
Professor Sørensen is currently a Clinical Professor and Chair at Department of Clinical Medicine - Department of Clinical Epidemiology, specialising in internal medicine and hepatology. He is a member of the Member of the Novo Nordisk Prize Committee, and Chairman of the Danish Agency for Registry Research, Ministry of Science, Technology and Innovation. He has a substantial number of publications within the field of clinical epidemiology, pharmacoepidemiology, and determinants of the prognosis of cardiovascular, infections, gastrointestinal, and cancer diseases.
Prof. Alma B. Pedersen
Department of Clinical Epidemiology,
Aarhus University Hospital, Aarhus University, Denmark
Professor Pedersen is a current Professor at Department of Clinical Medicine - Department of Clinical Epidemiology, conducting research using clinical quality databases and medical registries. Her research interest is in clinical epidemiology, surgical patient safety, and postoperative complications. She has special focus on the prognosis of orthopedic surgery patients, in particular hip fracture patients
University of Eastern Finland
Prof. Anna Maija Tolppanen
School of Pharmacy, University of Eastern Finland,
Finland
Doctor Anna Maija Tolppanen is currently a tenured Professor at University of Eastern Finland. Her group applies a variety of methods, ranging from traditional statistical methods to machine learning. Her work has provided important insights into drug utilization and associated adverse events in people with Alzheimer’s disease, as well as risk factors of Alzheimer’s disease and dementia.
Prof. Sirpa Hartikainen
School of Pharmacy, University of Eastern Finland,
Finland
Professor Sirpa Hartikainen is the professor of geriatric pharmacotherapy in the School of Pharmacy at University of Eastern Finland. Her research interest is in geriatrics and register-based studies of major neurodegenerative diseases Alzheimer’s disease and Parkinson disease. The focus has been in risk factors of these diseases, fall related injuries like fractures, drug utilization and associated adverse events.
University of Bordeaux
Pr. Cécile Droz-Perroteau
Bordeaux PharmacoEpi,
University of Bordeaux, France
Pr Cécile Droz-Perroteau is the Director at Bordeaux PharmacoEpi (BPE), University of Bordeaux. She has supervised the activities of BPE pharmacoepidemiology research platform of CIC 1401 "Pharmaco-epidemiology" and participated in more than 100 projects. This platform aimed at evaluating the behaviours of prescription and use of drugs as well as their consequences in terms of health and costs on a large scale.
Dr. Pauline Bosco-Levy
Bordeaux PharmacoEpi,
University of Bordeaux, France
Doctor Pauline Bosco-Levy is currently a Researcher at Bordeaux PharmacoEpi, University of Bordeaux, working as a Hospital-University Assistant. Her research interests is in Pharmacoepidemiology, Heart Failure and Cardiac decompensation.
Erasmus University Medical Center Rotterdam
Dr. Katia MC Verhamme
Department of Medical Informatics,
Erasmus MC,
Rotterdam, The Netherlands
Doctor Verhamme is currently an Associate Professor in Pharmaco-epidemiology at Erasmus Medical Center, The Netherlands. Her focus of research lies on Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pharmacoepidemiology and Primary Care.
University of Oxford
Prof. Dani Prieto-Alhambra
Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences,
University of Oxford, Oxford, United Kingdom
Prof Dani Prieto-Alhambra is currently an epidemiologist using routinely collected health data to generate reliable evidence for improved patient care here at the Centre for Statistics in Medicine in NDORMS. He leads Pharmaco- and Device Epidemiology research at NDORMS, and have experience designing, analysing and interpreting electronic medical records from around the world.